Home › This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
 

Keywords :   


This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

2015-02-02 16:11:55| Chemicals - Topix.net

If Ophthotech's late-stage trials pan out, Ophthotech could have a billion-dollar blockbuster drug on its hands. First, a bit of background The drug Ophthotech is developing is Fovista, a possible treatment for wet-stage, age-related macular degeneration -- one of the most common forms of vision loss among aging Americans.

Tags: this share market capture

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
25.11
25.1124cm
25.11! CDBest
25.1110
25.11 Y0385
25.11101138
25.11SideM Blu-ray
25.11 15th Anniversary CD & DVD BOX CLAMPAZAR
More »